Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

Clinical trial NCT00447330 · COMPLETED

Trial details

NCT number: NCT00447330
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Neoplasms Stomach Neoplasms Neoplasm Metastasis

Start date: 2007-02-01
Primary completion: 2014-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.